We are live on ! Find out more
FVFI

Flagship Ventures Fund IV Portfolio holdings

AUM $382M
This Fund
S&P 500
This Quarter Est. Return
-24.11%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$382M
AUM Growth
Cap. Flow
+$375M
Cap. Flow %
98.23%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
1
Seres Therapeutics
MCRB
$49.5M
$374M 97.96%
+704,179
New +$368M
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
$7.31M 1.92%
+148
New +$6.54M
CARM
3
DELISTED
Carisma Therapeutics
CARM
$469K 0.12%
+73,321
New +$1.01M

Similar funds

Flagship Ventures Fund IV's Q1 2016 Portfolio in Review

Q1 2016 is the first quarter with a 13F filing on record for Flagship Ventures Fund IV, which disclosed 3 positions worth $382M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Seres Therapeutics: 704,179 shares worth $374M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets.

  • Flagship Ventures Fund IV's largest Q1 2016 buy was Seres Therapeutics: 704,179 shares worth $374M.
  • Flagship Ventures Fund IV's ten largest holdings make up 100% of its $382M portfolio in Q1 2016.
  • Flagship Ventures Fund IV disclosed 3 positions in Q1 2016, its first 13F filing on record.

Based on Flagship Ventures Fund IV's 13F filing for Q1 2016, filed 13 May 2016.